Skip to content

James M. Inhofe bought Intellia Therapeutics (NTLA) on Oct 19, 2017

Data as of Oct 16

▲ BUY$15K–$50KJames M. Inhofe Rep · Senate · OKNTLA Intellia Therapeutics, Inc.
Watch NTLA
Traded
Oct 19, 2017
Disclosed
Nov 23, 2017
Filed
35 days after the trade

The STOCK Act allows 45 days to report a trade.

Official filing (Senate eFD) ↗

The price around the disclosure

NTLA since disclosure
Price history isn't loaded for NTLA yet
Similar stocks (XLV) since disclosure
Price history isn't loaded for NTLA yet
XLV — its sector index fund

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▲ BUYJames M. Inhofe Rep · Senate · OKCRSP CRISPR Therapeutics AG$15K–$50Kdisclosed Nov 23, 2017 · filed 35 days after the trade
  2. ▲ BUYJames M. Inhofe Rep · Senate · OKEDIT Editas Medicine, Inc.$15K–$50Kdisclosed Nov 23, 2017 · filed 35 days after the trade

See all of James M. Inhofe's trades →See every trade on NTLA →